AUSA — Australis Capital Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMicro Cap
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.13 | 0.221 | 0.717 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | -0.203 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.005 | -0.001 | 7.59 | 16.7 | 25.6 |
Operating Profit | -0.005 | 0.001 | -7.46 | -16.5 | -24.8 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.051 | -0.043 | -4.17 | -23.3 | -25.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.051 | -0.043 | -4.17 | -23.3 | -25.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.051 | -0.043 | -4.17 | -23.3 | -25.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.051 | -0.043 | -4.17 | -23.3 | -25.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0 | -0.006 | -0.131 | -0.103 |
Dividends per Share |